Page last updated: 2024-11-08

methylphosphonothiolate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID197063
CHEMBL ID122577
CHEBI ID187906
SCHEMBL ID26114
MeSH IDM0146428

Synonyms (15)

Synonym
brn 2345158
phosphonothioic acid, methyl-
methylphosphonothioic acid
methylphosphonothiolate
bdbm50131869
CHEMBL122577 ,
methyl-phosphonothioic acid
dihydroxy-methyl-sulanylidene-lambda5-phosphane
CHEBI:187906
5994-73-0
methanephosphonothioic acid
AKOS006277926
SCHEMBL26114
DTXSID70208652
dihydroxy-methyl-sulfanylidene-lambda5-phosphane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organothiophosphorus compoundAn organothiophosphorus compound is an organophosphorus compound which contains a phosphorus-sulfur bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
dephosphorylationAlkaline phosphatase, germ cell typeHomo sapiens (human)
defense responseProtein tyrosine phosphatase receptor type C-associated proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
alkaline phosphatase activityAlkaline phosphatase, germ cell typeHomo sapiens (human)
metal ion bindingAlkaline phosphatase, germ cell typeHomo sapiens (human)
protein bindingProtein tyrosine phosphatase receptor type C-associated proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
extracellular regionAlkaline phosphatase, germ cell typeHomo sapiens (human)
plasma membraneAlkaline phosphatase, germ cell typeHomo sapiens (human)
side of membraneAlkaline phosphatase, germ cell typeHomo sapiens (human)
plasma membraneAlkaline phosphatase, germ cell typeHomo sapiens (human)
plasma membraneProtein tyrosine phosphatase receptor type C-associated proteinHomo sapiens (human)
plasma membraneProtein tyrosine phosphatase receptor type C-associated proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID164683Inhibitory activity against Serine/Threonine Protein phosphatase 2C (PP2C)2003Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
AID213547Inhibitory activity against Tyrosine phosphatase from Yersinia (Yop protein)2003Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
AID32833Inhibitory activity against Escherichia coli Alkaline Phosphatase; no inhibition2003Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
AID159822Inhibition of Human Placental alkaline Phosphatase (PLAP)2003Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
AID99563Inhibitory activity against Serine/Threonine Protein Phosphatase (Lambda protein phosphatase)2003Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]